AWH - Aspira Women's Health slips 23% on common stock offering
- Aspira Women’s Health ( NASDAQ: AWH ), a provider of diagnostic tests for gynecologic disease, lost ~23% in the post-market trading Monday after the company announced an underwritten public offering of its common stock and warrants.
- AWH has selected William Blair as the sole book-running manager for the offering. The offering is subject to market and other closing conditions, the company said, adding that there is no assurance whether or when it will be completed or regarding the terms and actual size.
- AWH plans to use the proceeds for working capital and other general corporate purposes as well as for investments in complementary businesses, strategic partnerships, technologies or other intellectual property.
- In terms of current analyst ratings, Aspira Women’s Health ( AWH ) commands a Strong Buy recommendation on Wall Street while Seeking Alpha’s Quant System indicates a Hold rating.
For further details see:
Aspira Women’s Health slips 23% on common stock offering